2seventy bio is a US-based cell and gene therapy company that develops and commercializes cancer treatments. Its product pipeline includes CAR-T cell candidates for multiple myeloma. The company collaborates with Bristol-Myers Squibb and was founded in 2021, with headquarters in Cambridge, Massachusetts.